Member Info for jdt1990

I think the Moderna vaccine coming out as being essentially 95% effective based on 95 people has diluted the impact of any vaccine news for a while. To be able to roll this out on a mass scale its going to require a hell of a lot more work and trials.
Not to mention the logistics of getting the world vaccinated. Even if the UK gets 120m doses tomorrow to cover the uk population. Nobody knows how long its effective for and there is a world outside of the UK which many seem to forget.
Al mentioned manufacturing in Asia......manufacture close to your clients? I think the UK govt will need some and get some AVCT LFT's but theres going to be huge demand further afield. Asia / South America

Why is everyone who has an opinion a deramper?
"Not sure if our seller will return, would nice for this to rise in anticipation news."
Why is it always MM games, a big seller in the background, big buying pressure soon being held back...
There is a very economically viable project waiting in the wings but this isn't rising in anticipation of news because the anticipation is that it wont be the positive JV news we have been told (explicitly in an RNS). It's that simple.
Do you not admit this is a distinct possibility and if that is the case, further delays will stretch the ever thinning cash resources of the company which (to date) are being used to pay rather large salaries for no end product.

exactly - for those saying we have no working products. BAMS is there to buy...

https://www.adeptrix.com/store#!/SARS-CoV-2-S1-Glycoprotein-Assay/p/234586062/category=0

I do agree there Sharesurfer on the impact of further delays with regards to available funding. Plenty of money going out the door but need to line the coffers pretty sharpish to sustain that. Any company LC is involved in pays a nice juicy salary regardless of balance sheet strength!

Yeah its only 1.3% of current issued shares. You could argue if they are converting now they see potential upside and are unlikely to sell. They could have converted 3 weeks ago at 3p+ and sold for >100%.....

AVCT are on the official MSCI additions list for 30th Nov
https://app2.msci.com/eqb/gimi/smallcap/MSCI_Nov20_SCPublicList.pdf
If the last 4 years has taught us anything its not to take what's on twitter as gospel!

AS has also stated he believes we will sell every test we can produce. Currently the "competition" can do that because there is no alternative and huge demand. As this market grows and evolves the demand will be for top class tests and the early front runners will see demand dwindle. For me its either sell a few average tests early doors because perfecting the test and building scalable manufacturing capabilities takes "too long". OR take the time to create a top of the class test that can be mass produced and sold in huge volume LONG TERM.
Now, there is still a risk AVCTs test is poor S&S, production volumes are low etc but I just don't see that happening. When this test comes, if AS doesn't sell all we can produce maybe I will be a bit miffed. However, until then I would rather be part of the long game than a few cheap tests out the back of Del Boys van.
2 types of investor here. Covid investors - I get the frustration but the constant moaning and AS bashing will come up against some criticism from LTH who understand AVCT haven't had billions of $ in the bank, unlimited staff, govt funding, monster R&D tax breaks etc to do any of this. They have had to start at grass roots and build up, whilst protecting the therapeutics business they started out as....quite remarkable when you think about it.

I have to disagree here Tony and Sagetrade. I fully understand peoples frustrations at the delay of the LFT and think AS was naive with his timelines of summer. But this is the pharma industry and things take time. Would have been better business not to get carried away with timelines but you never know, he could have been told that by the third parties who are the major contributor here.
To your point of why aren't we being talked about? And missing the boat...
AVCT set out to become a household name through their Affimer IP and cancer therapeutics, not a LFT for a pandemic that came out of the blue.
Affimers are used in the Covid products but this in far from their only use case, so in complete contrary to your point, a rushed, sub standard test would actually be the reason AVCT missed out on being a household name. Not to mention the knock on impact on the therapeutics side.
How does this sound as a tagline "PreCision cancel therapy....coming to you from AVCT, the makers of a cr*p LFT test we bundled together to make a few quid during the pandemic"
Not sure thats what I invested here for?
So I am more than happy for AS to do it properly first time, even if it takes a bit longer.

I think there are plenty here ivans who are aware of Christian Schaffalitzky's involvement in KIBO and the fact he and LC have delivered nothing but dilution and salaries for themselves over there. Many KIBO holders came here as this was yet another promising project they spun off, leaving KIBO shareholders with an indirect exposure that was being diluted to oblivion.
Lets hope they can finally pull something out of the bag and deliver some value across the board....we deserve it from them!

I 100% agree with you SirG but Be careful, you’ll be chased off this bb with a pitchfork for suggesting there is any validity behind people’s comments who have expressed caution. They’re all derampers who want a lower entry price apparently!

Thalidomide back in the 60s being a great example of that unknown which turned out pretty horribly!

Interesting investment strategy Phoenix. I certainly don't see speculation in the form of asking questions as ramping/deramping. I am simply trying to gain insights from other investors to add to my own knowledge and research to ascertain a valuation for this company (which I keep to myself) on which to base my exposure.
I fully agree 5p tomorrow 1p tomorrow unfounded price statements are dangerous and ramping/deramping.
However, if people didn't ask questions, speculate and offer their thoughts and expertise this would just be a forum for posting quotes from the RNS's. Sharing information and debate is just as important as what is RNS'd.
Nobody is obliged to trade off purely RNS info in the same way nobody is obliged to trade off information/opinions shared on this board. How you operate is your personal choice, that's fine and good luck to you.
If I want to ask the board for their opinion on something, I should be entitled to do so without you telling me I am a deramper and sell up/move on or my agenda is a cheap entry price. Nobody has to answer my questions but some on here like to discuss openly their thoughts and ideas which they are well within their rights to do (within the rules of price sensitive information and Market Abuse of course)

Agreed Carpenter - how do you make sure everyone has equal exposure (or potential exposure) to the virus? Quite feasible that a higher portion of the people getting the vaccine were "cautious stay at homers" and more placebo testers were "anti maskers" for example. Results are biased from the offset then.

Not quite EIE01. 15k people got a vaccine 15k got a placebo. They then took the first 95 who showed symptoms and of those, 90 had been given a placebo and 5 the vaccine.
They then use that to claim 95% protection.....its just too small of a sample to be publicly claiming those figures surely?

It's so true oxygen! Someone posted on here the other day the usual "AS needs to give us news...how can they produce a vaccine quicker than AVCT can produce a spit on pregnancy test."
My response was on the same lines as your point, AVCT haven't had billions of $ in the bank, unlimited staff, govt funding, monster R&D tax breaks etc to do any of this. They have had to start at grass roots and build up, whilst protecting the therapeutics business they started out as....quite remarkable when you think about it.
£520m eat out to help out cost the govt.....even 10% of that would have gone a long way here!

It's criminal that this is even allowed to be reported in the mainstream press in this way.
Headline:" Moderna: Covid vaccine shows nearly 95% protection"
Small Print: That is based on only the first 95 of 30,000 to show symptoms.
Pfizer the same, political, SP enhancing d*ck swinging and sadly your average Joe are the ones who really suffer as there wont be a mainstream vaccine for a good while yet. There's plenty more damage to be done to economies from Covid and as you say, printing money to prop up the fallout and cost of mass testing that will be required for the next 12 months.
Gold won't be in any trouble that's for sure.

It's criminal that this is even allowed to be reported in the mainstream press in this way.
Headline:" Moderna: Covid vaccine shows nearly 95% protection"
Small Print: That is based on only the first 95 of 30,000 to show symptoms.
Complete false hope for so many people - I'm not even talking the effects on the SP here as we know testing will be around for a longtime yet. But people who have lost or are on the brink of losing jobs/business see thins thinking things could be back to normal soon. Pfizer the same, political, SP enhancing d*ck swinging and sadly your average Joe are the ones who really suffer.

"So for your information if you talking about risks it’s deramping" - okay so by that logic we cant discuss risks and this bb can only be a forum for ramping then can it?
I merely raised the topic of how much the company would likely have to give away/dilute as part of the financing deal to get this off the ground (as I would want Graham Briggs in that room not LC given KAT will be on the back foot) and what the AISC of gold tailings was? Both of which could materially impact the value of my investment, I see material upside just trying to gauge in what range that could be.....
If you know the answer or have anything to contribute to that great. If not, don't just shout me down as a deramper and tell me to sell up.

Good to see someone else has a little bit of balance here sensetalka and understands there are some risks here but at £8m clearly significantly undervalued. It if not when on the financing deal and when it does, how good is it?
Clearly others on here see any mention of risk as deramping having had my previous post removed (not really sure why anyone would report it?) but hey ho, that's my contribution done and GLA.

Hindsight is wonderful thing Majorboy, could that be due to the three solid RNS's on the bounce?